Drugplain

Aspirin and Extended-Release Dipyridamole 25 mg/1

Aspirin and Extended-Release Dipyridamole · CAPSULE · AvKARE

No Recall History
Plain English

This medication combines aspirin and extended-release dipyridamole in a capsule that you take by mouth to help reduce the risk of stroke in patients who have had a previous stroke or transient ischemic attack. Both ingredients work together as blood thinners to prevent blood clots from forming.

Key Facts

Brand Name
Aspirin and Extended-Release Dipyridamole
Generic Name
Aspirin and Extended-Release Dipyridamole
NDC Code (Product)
42291-116
Manufacturer
AvKARE
Strength
25 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
ANDA206392
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
04/27/2017

Recall History

No Recall History

Frequently Asked Questions

What is Aspirin and Extended-Release Dipyridamole used for?

This medication combines aspirin and extended-release dipyridamole in a capsule that you take by mouth to help reduce the risk of stroke in patients who have had a previous stroke or transient ischemic attack. Both ingredients work together as blood thinners to prevent blood clots from forming.

Is Aspirin and Extended-Release Dipyridamole a controlled substance?

Aspirin and Extended-Release Dipyridamole is not classified as a controlled substance by the DEA.

What is the generic name for Aspirin and Extended-Release Dipyridamole?

The generic name for Aspirin and Extended-Release Dipyridamole is Aspirin and Extended-Release Dipyridamole. There are 2 other brand versions of Aspirin and Extended-Release Dipyridamole.

What is the NDC code for Aspirin and Extended-Release Dipyridamole 25 mg/1?

The NDC (National Drug Code) for Aspirin and Extended-Release Dipyridamole 25 mg/1 is 42291-116, listed by AvKARE.

Product NDC

42291-116

Package NDC

42291-116-60

Other Aspirin and Extended-Release Dipyridamole Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)